
Human brucellosis is a re-emerging zoonotic disease in Yunnan Province, China; however, the molecular epidemiological profile of circulating strains remains unclear. In this study, bacteriology, multilocus sequence typing (MLST), and core genome MLST (cgMLST) were applied to investigate the epidemiological relationships among strains. Bacteriological analysis revealed that among the 127 strains, nine were identified as Brucella melitensis ( B. melitensis ) biovar 1 and 118 as B. melitensis bv. 3, with these strains distributed across 13 cities and autonomous prefectures. Among the patients, 70.9% were male, 87.4% were livestock-exposed farmers, and 95.3% were aged 41–80 years, with infection peaking in the April–September agricultural season (70.1% of cases). The 127 B. melitensis strains were classified into two sequence types (STs): ST8 (n = 116) and ST39 (n = 11). ST8 is widely distributed in Northern China, whereas ST39 has mainly been reported in Southwestern China (Guizhou and Sichuan Provinces). These data indicate that B. melitensis sequence types ST8 and ST39 are jointly associated with the brucellosis epidemic in the human population of Yunnan Province. cgMLST analysis classified 127 strains into eight clusters (CI–VIII) and 21 STs, with 19 STs comprising strains from at least two cities isolated across two years. These findings suggest that the brucellosis epidemic in this region is driven by strains sharing a high degree of genetic homology. Global cgMLST analysis revealed high genetic similarity between the majority of strains in this study and isolates from Northern China, implying latent epidemiological links among these populations. Prioritizing dominant ST8 lineages is essential for effective brucellosis control and surveillance.
Laboratory propagation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is essential for virological research, but adaptation in commonly used non-human cells with low transmembrane serine protease 2 expression may alter phenotypes relevant to biosafety and risk assessment. This study aimed to determine how serial passage in African green monkey-derived Vero E6 cells affects the growth, entry pathways, pathogenicity, and transmission of a clinical Delta strain. The parental virus was serially passaged to generate two adapted variants, which were characterized by whole-genome sequencing, replication and competition assays, spike cleavage and membrane fusion analyses, receptor binding studies, and animal experiments. The first variant acquired spike substitutions P217S, S247R, and H655Y, whereas the second acquired G261R and a six-amino-acid deletion immediately upstream of the furin cleavage site, plus non-spike mutations. Both variants replicated more efficiently than the parental virus in Vero E6, LLC-MK2, Huh-7, and HeLa cells expressing human angiotensin-converting enzyme 2 (ACE2), but not in Caco-2 cells. Their phenotypes reflected altered use of human transmembrane serine protease 2 rather than altered human ACE2 binding; they showed increased affinity for African green monkey ACE2 but unchanged affinity for the human receptor. Despite enhanced growth in vitro , both variants exhibited reduced pathogenicity and transmission in animals. These findings demonstrate that Vero E6 passage can rapidly reshape spike function and select viruses with improved cell-culture growth but impaired protease-dependent fitness in vivo , supporting rigorous genomic and phenotypic monitoring of laboratory-propagated virus stocks before use.